Kymera Therapeutics, Inc. (KYMR) quarterly cash flow statement — complete operating, investing & financing history
Kymera Therapeutics, Inc. (KYMR) cash flow statement — 8-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -54.06M | -88.84M | -66.75M | -27.11M | -59.88M | -79.15M | -61.78M | -50.19M | -42.94M | -39.59M | 8.04M | -31.65M | -35.26M | -43.97M | -39.54M | -34.27M | -38.98M | -40.3M | -38.35M | -37.26M |
| Operating CF Margin % | -83.18% | -258.52% | -2333.81% | -980.82% | -521.82% | -358.14% | -835.6% | -1341.62% | -167.39% | -384.86% | 16.8% | -669.35% | -213.5% | -464.48% | -244.97% | -358.8% | -338.59% | -418.78% | -251.08% | -183.22% |
| Operating CF Growth % | 9.72% | -12.24% | -8.03% | 45.99% | -39.47% | -99.92% | -867.98% | -58.59% | -21.78% | 9.96% | 120.35% | 7.65% | 9.57% | -9.12% | -3.09% | 8.03% | -27.77% | -76.55% | -91.11% | -128.3% |
| Net Income | -61.21M | -69.23M | -86.98M | -82.17M | -76.61M | -65.58M | -70.75M | -62.49M | -42.06M | -48.56M | -14.37M | -52.87M | -38.8M | -40.93M | -34.87M | -43M | -40.26M | -36.68M | -33.9M | -28.58M |
| Depreciation & Amortization | 2.03M | 2.02M | 2.03M | 2.15M | 2.08M | 2.05M | 1.99M | 1.99M | 1.94M | 1.46M | 891K | 895K | 900K | 879K | 818K | 767K | 705K | 687K | 689K | 671K |
| Stock-Based Compensation | 18.94M | 16.01M | 14.45M | 15.8M | 15.42M | 14.23M | 13.8M | 14.9M | 14.34M | 11.97M | 10.9M | 11.65M | 11.18M | 9.38M | 8.91M | 9.08M | 9.62M | 7.87M | 8.68M | 7.4M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 32.61M | -2.73M | -2.04M | -1.36M | -2.12M | -2.52M | -10.22M | -5.96M | -27.94M | -6.33M | 11.14M | -1.15M | -16.54M | -5.25M | -16.57M | -2.56M | -8.88M | 1.18M | 1.64M | 1.68M |
| Working Capital Changes | -46.44M | -34.91M | 5.79M | 38.48M | 1.35M | -27.32M | 3.4M | 1.36M | 10.78M | 1.87M | -516K | 9.82M | 8M | -8.05M | 2.18M | 1.45M | -178K | -13.35M | -15.46M | -18.42M |
| Change in Receivables | -16.43M | 0 | 0 | 40M | -20M | -19.05M | 370K | 386K | 327K | 16.73M | -14.98M | 344K | -802K | -783K | 346K | -513K | -1.11M | 0 | 577K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.6M | 0 |
| Change in Payables | -3.94M | 8.82M | -1.49M | 0 | -4.13M | 3.92M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.44M | -1.03M | -2.92M |
| Cash from Investing | 20.05M | -142.84M | -394.4M | -235.3M | 60.02M | 48.62M | 68.57M | -157.68M | 15.64M | -330.61M | 18.95M | 60.51M | 35.84M | 24.58M | -49.67M | -37.48M | 81.8M | 25.86M | -68.02M | -136.86M |
| Capital Expenditures | -473K | -434K | -106K | -181K | -695K | -467K | -936K | 189K | -4.69M | -7.4M | -11.63M | -8.08M | -10.77M | -4.01M | -373K | -1.25M | -735K | -482K | -501K | -306K |
| CapEx % of Revenue | 0.73% | 1.26% | 3.71% | 6.55% | 6.06% | 2.11% | 12.66% | 5.05% | 18.28% | 71.95% | 24.28% | 170.85% | 65.21% | 42.35% | 2.31% | 13.05% | 6.38% | 5.01% | 3.28% | 1.5% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.18M | 5.81M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 2.73M | 2.04M | -235.12M | 2.12M | 2.52M | 69.5M | -157.87M | 20.33M | -323.2M | 30.58M | 68.59M | 46.61M | 28.59M | -49.29M | -36.23M | 82.54M | -1.18M | -5.81M | 0 |
| Cash from Financing | 14.42M | 18.77M | 705.22M | 39.51M | 245.73M | 258K | 2.77M | 250.92M | 1.41M | 353.76M | 1.93M | -206K | 1.3M | 1.16M | 1.95M | 150.5M | 364K | 185K | 2.05M | 246.04M |
| Debt Issued (Net) | 0 | -425K | -416K | -419K | -382K | -277K | -293K | -641K | -352K | -290K | 925K | -340K | -334K | -327K | -305K | -292K | -269K | -264K | -156K | -352K |
| Equity Issued (Net) | 14.86M | 19.19M | 705.63M | 0 | 246.11M | 535K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -29K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -436K | 0 | 0 | 39.93M | 0 | 0 | 3.06M | 251.56M | 1.76M | 354.05M | 1.01M | 134K | 1.64M | 1.49M | 2.26M | 150.79M | 633K | 449K | 2.24M | 246.39M |
| Net Change in Cash | -19.6M | -212.91M | 244.07M | -222.9M | 245.86M | -30.28M | 9.55M | 43.05M | -25.88M | -16.44M | 28.93M | 28.66M | 1.89M | -18.23M | -87.25M | 78.75M | 43.18M | -14.25M | -104.32M | 71.92M |
| Free Cash Flow | -54.54M | -89.27M | -66.85M | -27.29M | -60.58M | -79.62M | -62.72M | -50M | -47.63M | -46.99M | -3.58M | -39.72M | -46.02M | -47.98M | -39.91M | -35.52M | -39.72M | -40.78M | -38.85M | -37.57M |
| FCF Margin % | -83.9% | -259.78% | -2337.52% | -987.37% | -527.88% | -360.26% | -848.26% | -1336.57% | -185.67% | -456.82% | -7.48% | -840.21% | -278.71% | -506.83% | -247.28% | -371.85% | -344.97% | -423.79% | -254.36% | -184.73% |
| FCF Growth % | 9.97% | -12.13% | -6.59% | 45.42% | -27.2% | -69.42% | -1651.96% | -25.87% | -3.48% | 2.05% | 91.03% | -11.85% | -15.87% | -17.66% | -2.72% | 5.46% | -27.57% | -77.39% | -80.67% | -129.06% |
| FCF per Share | -0.56 | -0.92 | -0.79 | -0.31 | -0.75 | -0.99 | -0.78 | -0.66 | -0.65 | -0.66 | -0.06 | -0.68 | -0.79 | -0.82 | -0.69 | -0.65 | -0.77 | -0.79 | -0.76 | -0.74 |
| FCF Conversion (FCF/Net Income) | 0.88x | 1.28x | 0.77x | 0.33x | 0.78x | 1.21x | 0.87x | 0.80x | 1.02x | 0.82x | -0.56x | 0.60x | 0.91x | 1.07x | 1.13x | 0.80x | 0.97x | 1.10x | 1.13x | 1.30x |
| Interest Paid | 0 | 0 | 0 | 83K | 0 | 0 | 62K | 54K | 41K | 49K | 47K | 37K | 26K | 52K | 55K | 38K | 40K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |